Radboud University Nijmegen Medical Centre

Nijmegen, Gelderland 6525 GA

1 studies enrolling now · 5 studies all time

What they study most

BRAF or NRAS Mutant Metastatic Melanoma, Colitis, Ulcerative, Crohn Disease, Disease Crohn, Melanoma, Metastatic or Unresectable Cutaneous Melanoma, Moderately to Severely Active Crohn's Disease

Studies at this site

• VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease — Recruiting now
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• Determination of the Optimal Treatment Target in Ulcerative Colitis — Running, not enrolling
• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed